| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 10, 2026 | Heart Transplant Rejection Study Maps Molecular Divide Biopsy Grading Cannot See | By Joseph Blake
Published: Aug 10 2026, 11:00 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| Oct 13, 2025 | Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG | BOSTON, Oct. 13, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced at the American Society of Human Genetics Annual Meeting that it has added Houston-based Gene by Gene, a leading genetics la... |
| Aug 11, 2025 | Preventive Neurology: A Game-Changer for Alzheimer’s and Parkinson’s | Dr. Richard S. Isaacson, Neurologist at The Institute for Neurodegenerative Diseases (IND) Dr. Kellyann Niotis M.D. Neurologist at The Institute for Neurodegenerative Diseases (IND)
Hundreds of millions of people worldwide live with a high ... |
| Jun 28, 2023 | Как люди мамонта клонировали | ▎Как часто мы слышим о внеочередном исчезновении того или иного вида животных?
Увы, чаще чем хотелось бы. Вымирание случается в силу разных причин. И если человечество еще как-то пытается спасти тех, кто стоит на грани вымирания, то что дел... |
| May 31, 2023 | Data snapshot: France bucks global trend as agrifoodtech investment surges 39% in 2022 | Data snapshot is a regular AFN feature analyzing agrifoodtech market investment data provided by our parent company, AgFunder.
Click here for more research from AgFunder and sign up to our newsletters to receive alerts about new research re... |
| May 3, 2023 | Data snapshot: Agrifoodtech funding in Europe slumped 46% in 2022, but there were some bright spots | Data snapshot is a regular AFN feature analyzing agrifoodtech market investment data provided by our parent company, AgFunder.
Click here for more research from AgFunder and sign up to our newsletters to receive alerts about new research re... |
| Apr 28, 2023 | Critical-rated security flaw in Illumina DNA sequencing tech exposes patient data | The U.S. government has sounded the alarm about a critical software vulnerability found in genomics giant Illumina’s DNA sequencing devices, which hackers can exploit to modify or steal patients’ sensitive medical data.
In separate advisori... |
| Apr 3, 2023 | Digital health news, funding round up in the prior week; April 3, 2023 | SimpleTherapy bought PhysMetrics; Wellvana Health raised $84M; Parsley Health expanded to NY and CA
Top Health News
Mantra Health, a provider of virtual mental health services for college students, partnered with Togetherall, an online comm... |
| Jan 12, 2023 | The week in agrifoodtech: $42m for No Meat Factory, New Age Eats ‘lets go’ of pilot facility, Benson Hill co-founder passes away | This week, Canadian alt-protein startup No Meat Factory raised Series B funding, while down in the US, New Age Eats let go of its nearly completed pilot facility. There were two new deals for forestry-related projects along with new funding... |
| Dec 22, 2022 | Business
Business | Inscripta to close Boulder HQ, triggering ‘mass layoff’ | BOULDER — Inscripta Inc., a genomic-editing platform born out of the University of Colorado, is shuttering its Boulder research and development hub and headquarters, resulting in “mass layoff’ for employees at the site.
The surprise closure... |
| Oct 4, 2022 | Biomeme To Launch Portable Sample-To-Answer PCR System, Host-Response Testing | It also precipitated a dramatic expansion for Philadelphia-based mini PCR instrument and assay developer Biomeme.
The company is now using revenues from CAP and CLIA accredited testing labs it owns to create a sample-to-answer instrument an... |
| Aug 10, 2022 | IndyGeneUS AI & Aurum Institute Establish 500K Pan-African Genome Project on Blockchain-Secured Health Data Platform | IndyGeneUS AI and Aurum Institute Establish 500K Pan-African Genome Project Leveraging Blockchain-Secured Health Data Platform
All of the samples collected by the 500K Pan-African Genome Project will remain on the continent.”
— IndyGeneUS A... |
| May 18, 2022 | Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials | Despite a significant bear market affecting the public biotech sector, private companies are still managing to pull in VC-backed funding rounds. The latest such round comes out of North Carolina’s research triangle for ... |
| Dec 1, 2021 | Rising Cases of Early-Onset Colorectal Cancer Calls for Expanded Biotech Screening Methods | NEW YORK, Dec. 1, 2021 /PRNewswire/ -- Early onset colorectal cancer is currently on the rise [1], according to a new study [2] from the University of Colorado School of Medicine in Denver. The findings come just as the US Multi-Society Tas... |
| Dec 1, 2021 | Rising Cases of Early-Onset Colorectal Cancer Calls for Expanded Biotech Screening Methods | FN Media Group Presents Microsmallcap.com Market Commentary
NEW YORK, Dec. 1, 2021 /PRNewswire/ -- Early onset colorectal cancer is currently on the rise [1], according to a new study [2] from the University of Colorado School of Medicine i... |
| Jul 6, 2021 | What to know about Nextdoor as it goes public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Why universities should think beyond the degree From 2U
Nextdoor hit national headli... |
| Jul 6, 2021 | What to know about Nextdoor as it goes public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Nextdoor hit national headlines early in the pandemic as supply shortages turned the hyper-local ... |
| Jun 7, 2021 | Walmart is quietly plotting to expand its virtual medical services | Hello,
Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news: Walmart Health’s medical provider has quietly filed to operate in 16 more states; We just got more evidence both vaccine doses of Pfizer’s COVID-... |
| Mar 31, 2021 | 54Gene, COVID-19 and the prospects of Human Biotechnology in Nigeria | By Oluwabukunmi Familoye and Ikpeme Neto
Nigeria doesn’t contribute much to the global biotech industry which is estimated to be worth $833.34 billion with a Compound Annual Growth Rate (CAGR) of over 7.02% by 2027, but this is beginning to... |
| Feb 22, 2021 | The CEO of Color lays out how COVID-19 is reshaping the future of the $1.5 billion DNA testing startup | Othman Laraki. Othman This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redeem now
Insider sat down with Othman Laraki, CEO of Color, the onetime consumer genetics startup that achieved $1.... |
| Feb 5, 2021 | How will the Biden administration affect funding for life science research? | Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to senior editors Kyle Blankenship a... |
| Jan 4, 2021 | Genetic testing company Color raises $167M to roll out COVID vaccines | The company partnered with state and local governments to power their COVID testing initatives
COVID is going to have a profound effect on the healthcare space; some of those effects are showing themselves, such as with the rise of teleheal... |
| Dec 8, 2020 | Balaji Srinivasan: The Man Who Called COVID | At first, Balaji Srinivasan held his tongue about the coronavirus.
Years before he became an angel investor and intellectual firebrand of the cryptocurrency community, Srinivasan had co-founded a genetic testing company that was eventually ... |
| Oct 6, 2020 | The role of precision medicine in the pandemic response | Investments into precision medicine companies is rising, but how much has it helped?
What healthcare will look like when the COVID pandemic is over is tough to say right now. What new technologies will emerge from this? What new data sets a... |
| Apr 13, 2020 | Instrument-Free POC Molecular Coronavirus Test Being Developed by Sense | Article by Leo O'Connor, GenomeWeb
NEW YORK – Sense Biodetection is accelerating the development of an instrument-free molecular platform for SARS-CoV-2, the coronavirus that causes COVID-19, in a bid to provide more sensitive point-of... |
| Mar 17, 2020 | Softbank-Owned Patent Troll Now Promises To Grant Royalty-Free License For Covid-19 Tests; Details Lacking | Yesterday I wrote up a fairly insane story about how a Softbank-owned patent troll, Fortress Investment Group, through a shell company subsidiary, Labrador Diagnostics (which, despite its name, does not seem to do any diagnostics), using pa... |
| Mar 5, 2020 | General Catalyst’s Quentin Clark gets specific on SaaS, cloud maturity and startup valuations | General Catalyst, a well-known venture capital firm with at least billions in funds raised over time, has backed Hubspot, Jet, Ping Identity, and Kayak over the years.
And General Catalyst isn’t slowing down, taking part in ten known rounds... |
| Feb 11, 2020 | Trump’s proposed NIH cuts show disregard for importance of basic research | Granted, the cuts are unlikely to pass the Democrat-controlled House, and generous funding for the NIH has consistently enjoyed bipartisan support despite Trump’s past proposals to cut it. But the irony of cutting funding for the NIH while ... |
| Feb 4, 2020 | Three years after raising $450M, Andreessen is back with a new $750M life sciences fund | Life sciences is big business in venture capital land and firms are raising big dollars to find the companies that will lead the next healthcare revolution.
Chief among them is Andreessen Horowitz, which announced its third life sciences fu... |
| Nov 8, 2019 | Daily funding roundup - November 7th, 2019 | FamePick raised $4.6M; CrowdStreet landed $12M; Healthify and SquareFoot closed $16M
FamePick: FamePick is a platform for business-minded creators. FamePick raised $4.6m in Series A funding. The round was led by InterVest and individuals in... |
| Jul 30, 2019 | The Big Decline In This Stock Is A Gift To Investors | Despite technological advances, most of medicine is still stubbornly one-size-fits-all. But last month, we got one step closer to personalized treatments. |
| Jul 19, 2019 | Some of the top precision health startups funded in 2019 | The precision medicine space is expected to grow to over $216.75 billion by 2028
Precision health, which is medicine that is tailored to each individual person, using their genes to figure out what treatments will work best for that individ... |
| May 16, 2019 | Daily funding roundup - May 16th, 2019 | Core raises $4M; Retail Zipline secured $9.6M; Sawyer closed $11M; OpenFin landed $17M
Core: Core is a meditation experience and personalized wellness company. Core has raised $4 million seed funding round led by Spero Ventures along with B... |
| May 1, 2019 | Daily funding roundup - May 1st, 2019 | Allganize landed $3.4M; Vault Platform closed $4.2M; Pana raised $10M: DivvyCloud secured $20M
Allganize: Allganize provides the best-in-class Natural Language Understanding API and conversational AI for enterprises. Allganize has raised $3... |
| Apr 22, 2019 | Daily funding roundup - April 22nd, 2019 | Novo Labs raised $2M; Driveroo secured $3.1M; Nabis landed $4M; Bridge Connector closed $20M
Novo Labs: Novo Labs is a provider of conversational artificial intelligence services for large restaurant chains. Novo Labs has raised $2 million ... |
| Apr 4, 2019 | Inscripta Expands Series C Financing Round to $105.5M | NEW YORK (GenomeWeb) – Gene editing technology company Inscripta said today that it that its existing investors have agreed to contribute an additional $20 million to its previously announced Series C funding round, bringing the total raise... |
| Apr 1, 2019 | Daily funding roundup - April 1st, 2019 | Novo raised $4.8M; BillionToOne landed $15M; Academia.edu secured $16M; CollegeVine raised $24
Novo: Novo is a modern banking platform that gives startups and small business owners the technology they need to focus on their businesses. Novo... |
| Mar 26, 2019 | A new lawsuit involving Stanford and Sequoia Capital highlights fights to come over cell-free DNA testing | This morning, a publicly traded transplant diagnostics company called CareDx, along with Stanford University, sued another publicly traded genetic testing company, Natera, for patent infringement.
Much appears to be at stake, and it all cen... |
| Oct 25, 2018 | A Chinese company unveils a powerful new sequencer. But can it compete in the U.S.? | Nearly two years ago, the San Diego-based genomics giant Illumina reaffirmed its dominance of the DNA sequencing market when it announced a fast and powerful new machine, called the NovaSeq, that’s since been adopted in labs all over the wo... |
| Aug 10, 2018 | Race for Governor, Foxconn, Promega & More: This Week’s WI Watchlist | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Voters in Wisconsin will head to the polls on Tuesday, Aug. 14 to cast ballots in primary races for governor and other elected offices. Read on to learn about connections betw... |
| May 23, 2018 | A focus on cost instead of value threatens the future of personalized medicine | One size fits all never worked as a strategy for the fashion industry. Or the auto, furniture, and most other industries. It shouldn’t be the strategy for medicine either, but unfortunately more often than not it is. And it may stay that wa... |
| Apr 26, 2018 | The Golden State Killer case was cracked with a genealogy website. What does that mean for genetic privacy? | SAN FRANCISCO — The identity of one of California’s most notorious serial killers had been a mystery for decades — until this week, when law enforcement arrested a suspect. Investigators revealed on Thursday that they made the breakthrough ... |
| Apr 14, 2018 | Cancer patients are increasingly being treated based on their inherited genetics - and it's putting doctors in a difficult position | Hollis Johnson
Advertisement
Cancer doctors are increasingly turning to genetics test to help them treat their patients with advanced forms of cancer.
But as we learn more about the genetics, we're learning that a lot of it is connecte... |
| Mar 1, 2018 | Helix holds first close on a planned $200 million investment in its genetic services marketplace | Welcome to the future… where startups are willing to customize everything from a diet regimen to a workout plan, or family planning to personal fashion based on an individual’s genetic code.
Angling to be the go-to marketplace for these gen... |
| Jan 4, 2018 | Madryn Joins $200M Funding for SomaLogic | SomaLogic announced today that it has capped its $200 million funding round, anchored by iCarbonX with substantial investments from Nan Fung Life Sciences and Madryn Asset Management. The successful round will accelerate SomaLogic’s goal of... |
| Dec 6, 2017 | Myriad’s riskScore test for breast cancer risk adds a second layer of precision | To understand the product’s value, picture this scenario:
A woman in her late 30’s schedules an appointment with her obstetrician/gynecologist. She’s concerned, now that she’s getting older, about her risk of developing breast cancer. Sever... |
| Sep 25, 2017 | IdentiGEN’s DNA Analysis Tech Wins €17m Contract to Ensure Provenance of Switzerland’s Meat | In an unassuming business park in Dublin, Ireland is a room packed full of refrigerators and in those refrigerators is the DNA that can tell any Irish pub-goer the exact cow that they are eating for dinner. The business is called IdentiGEN,... |
| May 22, 2017 | Color secures widespread coverage for its hereditary cancer test | Announced Monday, the coverage comes through a new partnership with some of the largest payers in the U.S. The deal includes mega-insurers such as United Healthcare, as well as regional players like Blue Shield of California. Combined, the ... |
| May 11, 2017 | Cancer screening firm Guardant Health raises $360 million to sequence tumor DNA of 1 million patients | Guardant Health, a startup that’s been pushing to open a new front on the global war on cancer, has raised $360 million in a gargantuan round of funding led by a subsidiary of Japanese telecoms giant SoftBank, with participation from Sequoi... |
| May 11, 2017 | Cancer screening firm Guardant Health raises $360 million to sequence tumor DNA of 1 million patients | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Guardant Health, a startup that’s been pushing to open a new front on the global war on cancer, has raised $360 million in a gargantuan... |
| Mar 8, 2017 | Behind Grail, Illumina’s billion-dollar diagnostics startup | While the company hasn’t been particularly forthcoming with information, a lot can be gleaned from CEO Jeff Huber’s presentation at the Future of Genomic Medicine conference held in San Diego last week.
After over a decade at Google, Huber’... |
| Feb 6, 2017 | LabCorp reportedly planning $8B buyout of CRO | In an emailed statement, a LabCorp spokesperson said the company does not comment on market rumors.
It’s not the first time M&A negotiations have been leaked. In April 2016, Bloomberg reported that LabCorp was in talks to acquire INC Re... |
| Jan 17, 2017 | Bio-Rad acquires RainDance, partners with Illumina for single-cell analysis | The news comes less than a week after the launch of the Illumina Bio-Rad Single-Cell Sequencing Solution, announced during the J.P. Morgan Healthcare Conference. Combined, the two deals strengthen the company’s position in the high buzz fie... |
| Oct 25, 2016 | Balance of power shifts with Merck’s Keytruda first-line therapy approval in lung cancer | Total sales of Keytruda in 2015 reached $566 million, compared to $942 million by Opdivo. However, following Monday’s announcement, Bernstein analysts forecast an additional $1 billion in sales for Keytruda in 2017.
Another analyst agreed.
... |
| Jun 20, 2016 | Is enterprise genomics good enough yet? | Mark Kaganovich Contributor
Mark Kaganovich is the CEO and cofounder of SolveBio. Follow him on twitter at @markkaganovich.
More posts by this contributor
Genomics Needs A Killer App
Genomics will make the dream of targeted therapies a real... |
| May 19, 2016 | Morning Read: Theranos on death watch after voiding 2 years of test results | Theranos has thrown out all Edison test results from 2014 and 2015, according to an anonymous source cited by the Wall Street Journal. The former darling of Silicon Valley also has sent “tens of thousands” of corrected results reports to ph... |
| May 1, 2016 | Zika in 30 Seconds: Archives (May – July) | Saturday-Sunday, July 30-31 The big news right now Zika cases are surging in Puerto Rico, and health officials fear hundreds of babies could be born with severe brain defects (STAT) A study suggests that all strains of the Zika virus are of... |
| Apr 21, 2016 | Morning Read: Peter Thiel-backed Auris Surgical Robots acquires Hansen Medical for $80M | Medtronic voluntarily initiated a recall of nearly 10,000 battery packs for medical devices to monitor patients’ breathing after receiving reports of a defect that can cause heat damage. The battery packs are used for Covidien Oridion label... |
| Apr 15, 2016 | Morning Read: Merck is giving Gilead’s Hepatitis C drug Sovaldi a run for its money | A study published in JAMIA calls attention to some serious gaps in electronic medical record data that could affect clinical care, medical research, and public health. Among the findings, a record of acute psychiatric services was missing 8... |
| Apr 13, 2016 | Theranos CEO Elizabeth Holmes faces possible two-year ban from blood-testing industry | Elizabeth Holmes has spent months doing damage control. Now she’s fighting for survival.
The embattled chief executive of blood-testing company Theranos is facing a proposed sanction from regulators that would ban her from owning or running... |
| Jan 14, 2016 | #jpm16 Day 4 Buzz: Since when did tech have all the fun? | Photo: Flickr user Wally Gobetz
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent... |
| Jan 12, 2016 | #jpm16 Day 2 Buzz: But it’s supposed to be the most wonderful time of the year!? | Photo: Flickr user Allan Donque
Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the glo... |
| Jan 7, 2016 | Sierra Ventures Closes 11th Fund With $170 Million | Today, Sierra Ventures, a San Mateo, Ca.-based early stage technology venture capital firm, is announcing that it has closed its 11th fund with $170 million.
It’s an impressive amount, given that Sierra’s future was somewhat cloudy several ... |
| Jan 7, 2016 | Guardant Health, Which Tests for Cancer Through Blood Samples, Raises $100M In Series D Funding | Guardant Health, a three-year-old, Redwood Shores, Ca.-based company whose non-invasive genomic sequencing test for cancer requires just two vials of blood, has raised nearly $100 million in Series D funding roughly one year after closing o... |
| Dec 31, 2015 | Morning Read: Feds didn’t inspect Theranos for first two years | LIFE SCIENCES
A former Boston Scientific engineer just got slapped with a year in prison for stealing trade secrets related to the company’s balloon dilation catheters. –Mass Device
M&A deals in diagnostics and Omics life sciences tools... |
| Dec 11, 2015 | Broad Institute licenses CRISPR/Cas9 tech to Transposagen | The Broad Institute has licensed CRISPR technology several times now, as Genome Web points out – to Horizon Discovery, GE Healthcare, and Sigma-Aldrich.
[Image courtesy of BigStock Photos]
Promoted
Telemedicine’s potential to provide health... |
| Oct 30, 2015 | YC Digest – October 24-30 | Top Stories from the YC World October 24 through October 30, 2015
Y Combinator is hiring hackers
Jessica Livingston’s Product Hunt AMA
Continuity’s Ali Rowghani talks to CNBC about playing the long game in VC investing
YC Alum
Gobble (... |
| Oct 30, 2015 | YC Digest - October 24-30 | Top Stories from the YC World October 24 through October 30, 2015
Y Combinator is hiring hackers
Jessica Livingston’s Product Hunt AMA
Continuity’s Ali Rowghani talks to CNBC about playing the long game in VC investing
YC Alum
Gobble (... |
| Sep 24, 2015 | Pathway Genomics gets FDA warning letter for its liquid biopsy test | Pathway has posted a white paper on its site that details the rationale for why its liquid biopsy test is sufficiently validated. But the FDA writes:
It is unclear how the literature that you cited, addressing the presence of circulating tu... |
| Aug 11, 2015 | CRISPR: Editas’ $120M proves it isn’t a bunch of hype. Here are 6 more biotechs shaping CRISPR landscape | But that’s already turned quickly on its head.
Confidence is growing in the technology, as evidenced by the title of a fantastic Wired article: “Easy DNA Editing Will Remake the World. Buckle Up.” And the broader scientific community is now... |
| Jul 2, 2015 | Five things you need to know about prenatal testmaker Natera’s $175M IPO | The company’s revenues grew from $55.2 million in 2013 to $159.3 million in 2014 — quite the increase. This comes largely from sales of the Panorama test – in the first three months of 2015 alone, it sold more than 55,000 of these tests.
Th... |
| Jun 19, 2015 | CMS put $2.8B at risk in 2014, Teva partners with Microchips Biotech (Morning Read) | Teva Pharmaceutical Industries entered a partnership with Microchips Biotech. Teva will make an upfront payment of $35 million in the form of an equity investment and technology access fee.
The partnership will explore the application of mi... |
| Jun 18, 2015 | 3 billionaire tech industry leaders will build robots, Allergan will pay $2.1B for double chin eliminator Kythera (Morning Read) | “As we enter the data technology era, robotics will become a critical field that catalyzes technological breakthroughs in numerous sectors such as healthcare, public services, research and at home,” said Ma, whose Alibaba Group is about 32%... |
| Jun 12, 2015 | Axovant Sciences IPO generates $2B+ valuation, NIH program tracks molecules affected by physical activity (Morning Read) | Given the fact that GlaxoSmithKline had a chance to take a look at this drug in the clinic, and concluded that they couldn’t do better than selling it for lunch money, the IPO terms illustrate the kind of overnight riches a select few can f... |
| Jun 11, 2015 | Jawbone files suit to halt Fitbit sales, study links acid reflux drugs with heart attacks (Morning Read) | An FDA panel gave a thumb’s up for Amgen cholesterol injection Repatha.
Melinta Therapeutics raised $67 million to advance its antibiotic for drug-resistant infections through a Phase 3 clinical study.
The Coriell Institute for Medical Rese... |
| May 22, 2015 | Funding roundup - week ending 5/22/15 | Oradian, WePay, MuleSoft, Videopixie, OnboardIQ, Mobcrush, Taboola, Lookup, Metabiota, Centro, Fuze
Seed stage
Oradian, a developer of technology platforms for microfinance institutions, raised an undisclosed amount of seed funding from Cre... |
| Apr 24, 2015 | Funding roundup - week ending 4/24/15 | Freshdesk, Oscar, Color Genomics, Gravie, Full Measure Education, Sulekha, Music Messenger, Onfleet
Seed stage
Digital wallet CoinTent raised a $1 million seed round from Foundry Group, QueensBridge Venture Partners, Mark Pincus, Donna Dubi... |
| Apr 20, 2015 | Early Twitter Vets Launch Color Genomics To Make Genetic Screenings For Breast Cancer Affordable | I’m always excited when an experienced team from the consumer mobile world crosses over into a complex and formidable area like healthcare or biotech. With Color Genomics, we’re getting just that.
Elad Gil and Othman Laraki, who sold Mixer ... |
| Apr 17, 2015 | Funding roundup - week ending 4/17/15 | Sprig, Planet Labs, Courion, NEA, Ascend, Snaps, Acorns, Skyport, 99designs, Adallom, Ticketbis, Ola
Seed stage
Financial technology startup Ascend Consumer Finance raised $1.5 million in seed funding, The round was led by Mucker Capital, w... |
| Apr 7, 2015 | Plenty of IPO movements and Margaret Hamburg has a new job (Morning Read) | If you didn’t get your fill of the Mark Cuban discussion last week this should fill you up (and this too).
LIFE SCIENCE
Aduro Biotech had upped its IPO goal to $93 million.
Medical device manufacturer InfaredX withdrew its IPO registration,... |
| Mar 24, 2015 | Tenet inks deal to become largest outpatient surgery provider, Sen. Rubio inching toward presidential run with ACA alternative? (Morning Read) | Sen. Marco Rubio (R-Fla.), who might be looking for a spot in the White House, outlined an Obamacare alternative that he suggested could be put in place if the Supreme Court rules against the law. Does his plan actually hold water, though?
... |
| Mar 10, 2015 | Wisconsin Roundup: Epic, Exact, Elli Health, StartupChicks, & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Here is a collection of recent headlines in Wisconsin’s technology and innovation community:
—Elli Health, a Delafield-based startup whose software enables virtual doctor visi... |
| Feb 13, 2015 | UNC spinout looking to one-up Kalydeco with one-size-fits-all cystic fibrosis therapy | Spyryx has more than $100,000, largely from angel investors, though it also has taken out a loan from the North Carolina Biotechnology Center. Spyryx is aiming to raise a Series A round and also study the drug’s efficacy in COPD, though it’... |
| Feb 3, 2015 | Guardant Health Secures $50 Million In Series C To Help More Doctors Track Cancer In Real Time | Guardant Health announced today that it has raised $50 million in Series C funding for its biopsy-free blood cancer screening test Guardant360. This puts the total funding for the medical technology startup at $90 million. Lightspeed Ventur... |
| Jan 15, 2015 | #JPM15 Day 3 Buzz: We’ve captured the mood at JP Morgan – and that mood is oh so good | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R... |
| Jan 14, 2015 | #JPM15 Day 2 Buzz: Drug pricing, catch-phrasing and positive vibes about healthcare | Photo from Flickr user Wally Gobetz
Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
T... |
| Jan 13, 2015 | #JPM15 Day 1 Buzz: Merck, Biogen & Bristol feeling good (plus the ‘other’ JP Morgan grows) | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| Jan 13, 2015 | The future of next-gen sequencing (and why an Illumina cofounder’s never had his genome mapped) | “It’s just that sequencing isn’t good enough today for many of the applications we’re looking at for future clinical use,” he said.
Stuelpnagel, who now chairs Ariosa Diagnostics, 10X Genomics and the just-acquired Sequenta, spoke this week... |
| Jan 5, 2015 | This BioPark-based company can detect nasty diseases. Now it’s expanding to China | A Baltimore-based biotech company that develops sensor systems to detect dangerous diseases was already poised for attention in early 2015: It planned to roll out a device that detects Ebola. Now the company is also looking to expand to Chi... |
| Oct 31, 2014 | Patrick Soon-Shiong startup gets $25M in personalized medicine space | NantWorks hasn’t much discussed what NantBioscience is up to – just that it’s all about “discovering knowledge at the protein level to develop drugs in pursuit of personalized medicine.”
But NantBioscience partnered with University of Color... |
| Sep 9, 2014 | “Deep sequencing” finds hidden causes of brain disorders | New methods can find mutations that strike just 1 in 10 cells in a sample.
By Nancy Fliesler
It’s become clear that our DNA is far from identical from cell to cell and that disease-causing mutations can happen in some of our cells and not o... |
| May 14, 2014 | Direct-to-consumer genetic testing: a case of potential harm | By Nancy Fliesler
Last November, the U.S. Food and Drug Administration issued a “cease and desist” order to 23andMe, a major purveyor of direct-to-consumer (DTC) genetic testing. In its letter to the company—issued after three prior warning... |
| Mar 26, 2014 | Ariosa, maker of a genetic test for pregnant women, files for a $69M IPO | Ariosa Diagnostics is already a favorite with pregnant women. But it’s about to become a big name on Wall Street, too, with its initial public offering.
Ariosa plans to offer $69 million in a proposed maximum aggregate offering price, but i... |
| Mar 18, 2014 | Genomic data mining firm hopes to help personalized medicine become commonplace in 3-5 years | He’s the founder of Expanse Bioinformatics, which has been building up a portfolio of algorithms and methodologies that may eventually enable doctors to recommend a course of treatment or a change in behavior to treat or prevent certain dis... |
| Dec 20, 2013 | Funding roundup - week ending 12/20/13 | Robinhood, Freshdesk, ResolutionTube, Freenom, Manalto, Soundhawk, Curoverse, Trinity Pharma
Seed stage
Robinhood, a mobile financial services company, raised a $3 million seed round, led by Index Ventures, with commitments from a16z seed, ... |
| Jun 11, 2013 | Molecular, genomic diagnostic service lab raising $900K to enable personalized medicine | As told by Greenville Business Magazine, the company’s history is a bit confusing, if not curious. It starts several years back with the formation of Selah Technologies, which Bolick started to commercialize nanotechnology from Clemson that... |
| Jan 27, 2013 | The personalized medicine revolution is almost here | Narges Bani Asadi is a founder and CEO of Bina Technologies.
We are at the dawn of a new age of personalized medicine.
Just as Moore’s law transformed computing — and, as a result, all aspects of our professional and personal lives — so, to... |
| Jan 27, 2013 | The personalized medicine revolution is almost here | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Narges Bani Asadi is a founder and CEO of Bina Te... |
| Jan 18, 2013 | Would You Give Birth To A Neandertal Baby? | MIT Technology Review spots a wild story on Genome Web about George Church, a molecular geneticist at Harvard, who is developing technology that can create Neandertal cells. Once he gets the cells, Church hopes to find an “adventurous femal... |
